aspirin has been researched along with kw 3635 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karasawa, A; Kubo, K; Shirakura, S | 1 |
| Higo, K; Karasawa, A | 3 |
| Higo, K; Karasawa, A; Shirakura, S; Takeda, M | 1 |
| Higo, K; Karasawa, A; Kobayashi, T; Satoh, H | 1 |
6 other study(ies) available for aspirin and kw 3635
| Article | Year |
|---|---|
Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Benzimidazoles; Benzoxepins; Blood Pressure; Death, Sudden; Dose-Response Relationship, Drug; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane A2; Thromboxanes; Ticlopidine | 1991 |
Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs.
Topics: Angioplasty, Balloon; Animals; Aorta, Thoracic; Aspirin; Benzimidazoles; Benzoxepins; Endothelium, Vascular; Epoprostenol; Guinea Pigs; In Vitro Techniques; Male; Methacrylates; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase | 1994 |
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood Platelets; Disease Models, Animal; Erythrocyte Count; Femoral Artery; Guinea Pigs; Lauric Acids; Male; Phenylacetates; Platelet Count; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxanes; Ticlopidine | 1994 |
The novel thromboxane A2 receptor antagonist KW-3635 abolishes the cyclic flow reduction in the canine carotid artery.
Topics: Animals; Aspirin; Benzimidazoles; Benzoxepins; Carotid Arteries; Dogs; Female; Fibrinolytic Agents; Male; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Regional Blood Flow; Thromboxane A2 | 1994 |
Protective effects of KW-3635, a thromboxane A2 antagonist, on arachidonic acid-induced transient cerebral ischemia in dogs.
Topics: Animals; Arachidonic Acid; Aspirin; Benzimidazoles; Benzoxepins; Blood Pressure; Carotid Arteries; Cerebrovascular Circulation; Dogs; Electroencephalography; Female; Heart Rate; In Vitro Techniques; Injections, Intra-Arterial; Ischemic Attack, Transient; Male; Platelet Aggregation; Thromboxane A2 | 1994 |
Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
Topics: Animals; Arachidonic Acid; Aspirin; Benzimidazoles; Benzoxepins; Collagen; Disease Models, Animal; Femoral Artery; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation; Sulfonamides; Thrombosis; Thromboxane A2 | 1993 |